Advances in Myeloma Treatment | CAR T-Cell Therapy and Bispecific Antibodies
https://vimeo.com/824116067 How are new treatments impacting the landscape of myeloma care? Dr. Francesca Cottini explains the role of bispecific antibody therapy and CAR T-cell therapy and how these emerging therapies…
Making Treatment Decisions | Understanding Common Myeloma Therapies
https://vimeo.com/824116525 What are common myeloma therapies, and when are they used? Dr. Ashley Rosko outlines the factors that impact treatment decisions and reviews available therapies including stem cell transplant, proteasome…
How Close Is Personalized Medicine for Myeloma?
https://vimeo.com/824116217 Therapy targeting specific mutations or abnormalities is becoming increasingly common in cancer care, but are we there in myeloma? Dr. Ashley Rosko discusses how clinicians are using test results…
How Are Myeloma Patients in Remission Monitored?
https://vimeo.com/823417381 How often should testing be administered when myeloma is in remission? Dr. Brandon Blue discusses how patients in remission are monitored and when a bone marrow biopsy may be…
Accessing Personalized Myeloma Treatment | What Patients Should Know
https://vimeo.com/823455201 Myeloma experts Dr. Francesca Cottini and Dr. Ashley Rosko provide an overview of the latest advances in essential testing for myeloma and explain how results could affect care and…
Expert Perspective: COVID Vaccines and Treatment for Myeloma Patients
https://vimeo.com/779453073 Myeloma expert Dr. Irene Ghobrial shares an update on COVID vaccines, treatment, and advice for myeloma patients on how to help protect themselves from the virus. Dr. Irene Ghobrial…
How Is Myeloma Treatment Response Measured?
https://vimeo.com/779453142 Myeloma expert Dr. Betsy O’Donnell reviews the terms that define myeloma treatment response, such as complete remission (CR) and partial remission (PR). Dr. O’Donnell goes on to discuss the…
Which Myeloma Patients Are Candidates for CAR T-Cell Therapy?
https://vimeo.com/779453039 Myeloma specialist Dr. Omar Nadeem discusses which patients are most appropriate for CAR T-cell therapy and explains cytokine release syndrome (CRS), which may arise following this treatment approach. Dr….
How Is Relapsed or Refractory Myeloma Managed?
https://vimeo.com/779452757 Drs. Irene Ghobrial and Betsy O’Donnell discuss next steps if myeloma relapse occurs or the disease doesn’t respond to treatment. The experts review the necessary tests following a myeloma…
How Are Patients on Myeloma Maintenance Therapy Monitored?
https://vimeo.com/779453217 Myeloma specialist Dr. Omar Nadeem explains how a follow-up care and monitoring plan for patients on maintenance therapy is determined. Dr. Omar Nadeem is the Clinical Director of the…
How Is Research Advancing Myeloma Treatment and Care?
https://vimeo.com/779453322 A panel of myeloma experts, including Drs. Omar Nadeem, Irene Ghobrial, and Betsy O’Donnell, discuss how clinical trials advance myeloma research and share an update on promising therapies in…
What Are Currently Available Myeloma Treatments?
https://vimeo.com/779453261 Dr. Omar Nadeem reviews myeloma treatment classes, including immunomodulatory therapies, proteasome inhibitors, and monoclonal antibodies. Dr. Nadeem also discusses how combining these therapies has boosted the effectiveness of myeloma…